Cero Therapeutics Holdings, Inc.
CERO· OTC
CEROCero Therapeutics Holdings, Inc.
Quarterly figures for Cero Therapeutics Holdings, Inc., with source filings when available.
17 quarters. Sep 30, 2021 to Jun 30, 2026. mixed units.
Cero Therapeutics Holdings, Inc. has filed its 10-Q within 45 to 53 days of period end across its last 8 quarters. The 10-K runs 83 to 105 days.
Cero Therapeutics Holdings, Inc. · CIK 1870404 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | — | — | -$0.70 | |
| Q1 2026 | Mar 31, 2026 | — | May 15, 2026 | 45 d | 10-Q | ||||
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Apr 15, 2026 | 105 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 19, 2025 | 50 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q3 2024 | Sep 30, 2024 | Oct 11, 2024 · after-hours | Nov 19, 2024 | 50 d | 10-Q | — | — | -$170.22 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 2, 2024 | 93 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 9, 2023 | 40 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 24, 2023 | 83 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 10, 2022 | 41 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q3 2021 | Sep 30, 2021 | — | Nov 19, 2021 | 50 d | 10-Q | — | — | $0.00 | |
| — |
| — |
| -$0.20 |
| — |
| — |
| -$9.10 |
| Q2 2025 | Jun 30, 2025 | — | Aug 22, 2025 | 53 d | 10-Q | — | — | -$61.71 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | — | — | -$31.82 |
|---|
| — |
| — |
| -$302.32 |
| — |
| — |
| -$0.15 |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | — | — | -$0.23 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 12, 2023 | 42 d | 10-Q | — | — | -$0.27 |
|---|
| — |
| — |
| — |
| Q2 2022 | Jun 30, 2022 | — | Aug 11, 2022 | 42 d | 10-Q | — | — | — |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 13, 2022 | 43 d | 10-Q | — | — | — |
|---|
